Elizabeth A. Marchant
About Elizabeth A. Marchant
Elizabeth A. Marchant is a Senior Scientist specializing in Translational Science, with expertise in generating data from patient-derived material to assess cell therapy programs. She has over seven years of experience in immunology research, particularly in T cell and innate immune responses.
Work at Adaptimmune
Elizabeth A. Marchant serves as a Senior Scientist in Translational Science at Adaptimmune, a position she has held since 2020. In this role, she focuses on generating robust data from patient-derived material to evaluate cell therapy programs. Her expertise in translational science contributes to the advancement of therapeutic strategies within the organization.
Education and Expertise
Elizabeth Marchant has a strong academic background in the life sciences. She earned a Bachelor of Science in Integrated Science with a focus on Animal Ecology and Host-pathogen relationships, along with a minor in Political Science from The University of British Columbia. She further pursued her studies at The University of Western Australia, obtaining a Master of Infectious Diseases. Elizabeth completed her Doctor of Philosophy (PhD) in Experimental Medicine at The University of British Columbia, enhancing her expertise in immunology and cell therapy.
Background
Elizabeth A. Marchant is a dual national of Canada and Ireland, which provides her with work flexibility across the EU and the UK. Her professional journey includes various roles in research and management, notably at BC Children's Hospital Research Institute, where she worked as an Immunology Research Scientist and later as a Laboratory Manager. She also served as a Postdoctoral Research Fellow at the same institution before transitioning to the biopharmaceutical sector.
Achievements
Elizabeth has received multiple awards for her oral and poster presentations, showcasing her effective communication skills in the field of research. Her experience spans over seven years in utilizing flow cytometry, ELISA, and functional readouts to study T cell and innate immune responses, underscoring her contributions to the scientific community.